Inventor
ROSARIO-JANSEN THERESA
US14 patents
⚠️ This page may combine multiple inventors who share the name “ROSARIO-JANSEN THERESA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HORIZON THERAPEUTICS USA INC
5 patentsUS11639927B2May 2, 2023
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
HORIZON THERAPEUTICS USA INC7 citations84
US11598767B2Mar 7, 2023
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON THERAPEUTICS USA INC5 citations84
US12560596B2Feb 24, 2026
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON THERAPEUTICS USA INC0 citations61
US12188927B2Jan 7, 2025
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
HORIZON THERAPEUTICS USA INC0 citations61
US11982670B2May 14, 2024
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON THERAPEUTICS USA INC0 citations61
PROCTER & GAMBLE
3 patentsUS5116520AMay 26, 1992
Fabric softening and anti-static compositions containing a quaternized di-substituted imidazoline ester fabric softening compound with a nonionic fabric softening compound
PROCTER & GAMBLE24 citations90
US4954635ASep 4, 1990
Process for preparing quaternized imidazoline fabric conditioning compounds
PROCTER & GAMBLE22 citations79
US5476876ADec 19, 1995
Di-tert-butylphenol compounds useful as anti-inflammatory agents
PROCTER & GAMBLE13 citations73
WATSON PHARMACEUTICALS INC
2 patentsROSARIO-JANSEN THERESA
2 patentsUS9377454B2Jun 28, 2016
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
ROSARIO-JANSEN THERESA33 citations95
US8551516B2Oct 8, 2013
Administration of non-oral androgenic steroids to women
ROSARIO-JANSEN THERESA2 citations59
HORIZON PHARMA RHEUMATOLOGY LLC
2 patentsUS10823727B2Nov 3, 2020
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON PHARMA RHEUMATOLOGY LLC12 citations92
US10139399B2Nov 27, 2018
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
HORIZON PHARMA RHEUMATOLOGY LLC11 citations91